共 50 条
- [23] Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (07): : 1008 - 1014
- [27] Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma? NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (08): : 388 - 389
- [28] A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study International Journal of Hematology, 2015, 101 : 554 - 562